Design and application of oncolytic HSV vectors for glioblastoma therapy
- 1 April 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 9 (4) , 505-517
- https://doi.org/10.1586/ern.09.9
Abstract
(2009). Design and application of oncolytic HSV vectors for glioblastoma therapy. Expert Review of Neurotherapeutics: Vol. 9, No. 4, pp. 505-517.Keywords
This publication has 129 references indexed in Scilit:
- Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-RenewalCancer Research, 2008
- Depletion of Peripheral Macrophages and Brain Microglia Increases Brain Tumor Titers of Oncolytic VirusesCancer Research, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- JAK-STAT signaling pathways are activated in the brain following reovirus infectionJournal of NeuroVirology, 2007
- Angiogenesis-independent tumor growth mediated by stem-like cancer cellsProceedings of the National Academy of Sciences, 2006
- Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesProceedings of the National Academy of Sciences, 2006
- Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth FactorCancer Research, 2006
- A microRNA polycistron as a potential human oncogeneNature, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971